Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

HMPWG consults on safety of homeopathic medicinal products from biological origin

15 Jan 2015

The Homeopathic Medicinal Products Working Group (HMPWG) of the Heads of Medicines Agencies has launched a public consultation on the safety of homeopathic medicinal products from biological origin. The original guideline were adopted in 2007; a revised version has now been published for consultation.

This guideline applies only to homeopathic medicinal products subject to simplified registration. It includes those starting materials obtained from:

  • humans, e.g. human cell lines, healthy tissues or fluids, or nosodes such as human lesions/infected materials;
  • animals e.g. whole animals, organs, tissues, animal secretions, toxins, healthy or diseased tissues and extracts (nosodes), blood products, parasites, animal cell lines;
  • micro-organisms (e.g. bacteria, viruses, microscopic fungi, plant parasites);

Plant materials and macroscopic fungi are outside the scope of the guideline.

The closing date for comments to the HMPWG is 10 April.